Pentoxifylline and Endometriosis (LETS1)

Hospital Clinic of Barcelona

Status and phase: Completed; Phase 3

Conditions: Endometriosis-Associated Infertility

Treatments: Drug: placebo; Drug: pentoxifylline

Study type: Interventional

Funder types: Other

Identifiers

NCT00632697

LETS

Details and patient eligibility

About

To prove efficacy of an immunomodulator called pentoxifylline in the treatment of endometriosis in infertile patients undergoing laparoscopy surgery

Enrollment: 104 patients

Sex: Female

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Infertile patients having early endometriosis as the only factor of their infertility

Exclusion criteria

• Previous treatment for endometriosis or patients having pelvic disorders in addition to endometriosis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

104 participants in 2 patient groups, including a placebo group

1

Active Comparator group

Treatment:

Drug: pentoxifylline

2

Placebo Comparator group

Treatment:

Drug: placebo